Microbial Drug Resistance: Mechanisms, Epidemiology, and DiseasePublished by Mary Ann Liebert Inc. This highly rated international journal provides a multidisciplinary forum for peer-reviewed original papers covering the mechanisms of antibiotic resistance, the molecular epidemiology of drug-resistant pathogens, and the impact of resistance on disease and chemotherapy. |
|
| Audience | Research scientists, clinicians and other health professionals |
| Frequency | 4 issues a year: Spring, Summer, Fall, Winter |
| Editorial Focus | Publishes original peer-reviewed papers, reviews, short communications, and other information from all sectors of the scientific and public health community which cover the most pressing issues in the field - from the molecular biology of resistance mechanisms, virulence genes, and disease through molecular epidemiology all the way to drug design, infection control, and medical practice. |
| Editor(s) in Chief | Alexander Tomasz, PhD The Rockefeller University, Laboratory of Microbiology, New York |
| Print Advertising Options | Adverts, Inserts & Supplements |
| Digital Advertising Options | Banners on website Banners on subscriber Table of Contents email alerts |
| Further Information | Heleen Vodégel Tel: +44 (0) 1875 825 700 hvodegel@impressmedia.com |
| Publisher | Microbial Drug Resistance is owned and published by Mary Ann Liebert, Inc. Editorial headquarters: 140 Huguenot Street, New Rochelle, New York 10801, USA. Phone: +1 (914) 740-2100. Fax: +1 (914) 740-2101 www.liebertpub.com |
